Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-046871

EVP & Chief Medical Officer sold 6,789 shares at $1.17 ($7,943)

From the SEC's structured data for this filing

Trades in this filing

Rangwala Reshma · EVP & Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-04-22 Sale : show line 1 in the form −6,789 $1.17 $7,943 342,931 D
Open-market sales · 6,789 sh · avg $1.17 · $7,943
Loading xslF345X05/ownership.xml…